Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
ClearPoint Neuro (CLPT) Stock Price & Analysis
254 Followers
CLPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.05 - $7.97
Previous Close$7.39
Volume92.00K
Average Volume (3M)212.06K
Market Cap
$202.64M
Enterprise Value$181.14M
Total Cash (Recent Filing)$35.40M
Total Debt (Recent Filing)$13.90M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Aug 07, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.83
Shares Outstanding27,420,327
10 Day Avg. Volume159,178
30 Day Avg. Volume212,064
Standard Deviation0.18
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)7.70
Price to Sales (P/S)6.47
Price to Cash Flow (P/CF)-33.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.92
Enterprise Value/Gross Profit13.31
Enterprise Value/Ebitda-9.04
Forecast
1Y Price Target
$10.00Price Target Upside35.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
ClearPoint Neuro News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceClearPoint Neuro reported Q1'24 revenue of $7.6M, exceeding expectations with top and bottom line growth.
Market PositionNew site activations and compatibility with the Rosa Robot position ClearPoint to access approximately 50% of the market.
Product DevelopmentClearPoint Neuro's recent FDA clearances and successful product installations set the stage for increased adoption and revenue from disposables and software upgrades.
Bears Say
Financial PerformanceEst. Cash Burn Rate $6.2 suggests a need for careful financial monitoring and potential future capital requirements.
Revenue DeclineFunctional neurosurgery navigation and therapy revenue declined both quarter over quarter and year over year.
Revenue DeclineFunctional neurosurgery revenue fell in Q1, but is expected to return to double-digit growth in Q2.
---
Ownership Overview
46.66% Insiders
7.97% Mutual Funds
5.50% Other Institutional Investors
39.87% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CLPT FAQ
What was ClearPoint Neuro’s price range in the past 12 months?
ClearPoint Neuro lowest stock price was $4.05 and its highest was $7.97 in the past 12 months.
What is ClearPoint Neuro’s market cap?
Currently, no data Available
When is ClearPoint Neuro’s upcoming earnings report date?
ClearPoint Neuro’s upcoming earnings report date is Aug 07, 2024 which is in 10 days.
How were ClearPoint Neuro’s earnings last quarter?
ClearPoint Neuro released its earnings results on May 07, 2024. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.19 by $0.03.
Is ClearPoint Neuro overvalued?
According to Wall Street analysts ClearPoint Neuro’s price is currently Undervalued.
Does ClearPoint Neuro pay dividends?
ClearPoint Neuro does not currently pay dividends.
What is ClearPoint Neuro’s EPS estimate?
ClearPoint Neuro’s EPS estimate is -$0.2.
How many shares outstanding does ClearPoint Neuro have?
ClearPoint Neuro has 27,420,326 shares outstanding.
What happened to ClearPoint Neuro’s price movement after its last earnings report?
ClearPoint Neuro reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.19. Following the earnings report the stock price went up 1.698%.
Which hedge fund is a major shareholder of ClearPoint Neuro?
Among the largest hedge funds holding ClearPoint Neuro’s share is Royce & Associates LLC. It holds ClearPoint Neuro’s shares valued at 199K.
---
ClearPoint Neuro Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (35.32% Upside)
$10.00 (35.32% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 23.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.99%
12-Months-Change
Fundamentals
Return on Equity
-61.42%
Trailing 12-Months
Asset Growth
6.75%
Trailing 12-Months
Company Description
ClearPoint Neuro
Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.
---
CLPT Earnings Call
Q1 2024
0:00 / 0:00
---
CLPT Stock 12 Month Forecast
Average Price Target
$10.00
▲(35.32% Upside)
Technical Analysis
Alphatec Holdings
―
Spero Therapeutics
―
Voyager Therapeutics
―
Inovio Pharmaceuticals
―
Best Analysts Covering CLPT
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
+0.75%
reiterated a buy rating 2 months ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +0.75% per trade.
---